Early amino-acid administration improves preterm infant weight

C J Valentine1, S Fernandez, L K Rogers

  • 1Department of Pediatrics, Neonatal Nutrition Team, Nationwide Children's Hospital, Ohio State University, Columbus, OH 43205, USA. Christina.Valentine@nationwidechildrens.org

Insights

Early amino acid supplementation for premature infants under 1500g improved growth outcomes. This early nutritional support is critical for better weight gain and development in high-risk neonates.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Perinatal Medicine

Background:

  • Premature infants, particularly those under 1500g, often experience suboptimal growth post-birth.
  • Inadequate early nutritional support is a significant factor contributing to poor growth in these vulnerable infants.

Purpose of the Study:

  • To investigate the impact of early amino acid administration on growth outcomes in preterm infants weighing less than 1500g.
  • To test the hypothesis that initiating amino acids within the first few hours of life reduces the incidence of infants falling below the 10th percentile at 36 weeks post-conceptual age.

Main Methods:

  • A prospective study compared early amino-acid (EAA) supplementation (initiated before 24 hours) with a retrospective cohort receiving late amino-acid (LAA) supplementation (initiated after 24 hours).
  • The primary outcome measured was the proportion of infants below the 10th percentile at 36 weeks post-conceptual age.

Main Results:

  • Significantly fewer infants in the EAA group fell below the 10th percentile compared to the LAA group (P<0.001).
  • EAA supplementation was associated with significantly greater infant weight gains (P<0.003) and a shorter duration of parenteral nutrition (P<0.001).

Conclusions:

  • Early amino acid administration in preterm infants (<1500g) is linked to improved weight gain.
  • Nutritional strategies including amino acids within the first 24 hours of life are crucial for optimizing growth in preterm neonates.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...